Quantcast
Last updated on April 19, 2014 at 12:41 EDT

Latest Antivirals Stories

2014-01-30 23:30:11

PositiveSingles members voted for their favorite topical anesthetic. Various prescription ointments and creams were among the favorites, with over-the-counter topical anesthetics ranking lower. Los Angeles (PRWEB) January 30, 2014 PositiveSingles.com has released the results of the latest survey with helpful information about dealing with HPV-2, also known as genital herpes. Members who have experience dealing with the painful blisters on their genitals and surrounding area during...

2014-01-29 23:32:21

Health and Harmony LLC now offers a natural way to increase the immune system, gain added protection against the flu, and offset the unwanted side effects that so many prescription drugs can cause with a natural, nonaddictive immune booster created by world-renowned immunologist Dr. Yasuhiko Kojima. Peoria, IL (PRWEB) January 29, 2014 Health and Harmony LLC now offers a natural way to increase the immune system, gain added protection against the flu, and offset the unwanted side effects...

2014-01-16 10:01:37

Study shows safe and simpler treatment for potentially deadly, liver-damaging disease Efforts to cure hepatitis C, the liver-damaging infectious disease that has for years killed more Americans than HIV/AIDS, are about to get simpler and more effective, according to new research at Johns Hopkins and elsewhere. In a study to be reported in the Jan. 16 issue of the New England Journal of Medicine, researchers say combination treatments involving a pair of experimental, oral antiviral...

2014-01-03 11:31:48

Mycobacterium tuberculosis is a major cause of death worldwide, and a formidable foe. Most healthy people can defend themselves against tuberculosis, but they need all parts of their immune system to work together. A study published on January 2nd in PLOS Pathogens reveals how a special class of immune cells called "invariant natural killer T cells" make their contribution to this concerted effort. "We were interested in identifying the mechanisms that different types of T cells use to...

2013-12-30 12:22:25

For the estimated 10 percent of patients whose bodies reject a corneal transplant, the odds of a second transplant succeeding are poor. All that could change, however, based on a UT Southwestern Medical Center study that has found a way to boost the corneal transplant acceptance rate. In the study, researchers found that corneal transplants in mice were accepted 90 percent of the time when the action of an immune system molecule called interferon-gamma (IFN-γ) was blocked and when the...

2013-12-27 23:04:33

“Should I take drugs for my herpes or not?” That is a recent topic on Positivesingles.com. Los Angeles (PRWEB) December 27, 2013 In December PositiveSingles.com hold a survey for members regarding whether or not they have taken their prescribed drugs since being diagnosed with herpes. 83.61% of members express that they typically take their prescribed drugs once being diagnosed with herpes. The medicines they usually take are valtrex 500 milligrams, lysin vitamins or garlic...

2013-12-24 13:31:09

The drug inosine appears to be a safe and effective way to raise blood and cerebrospinal fluid urate levels in patients with early Parkinson disease (PD), suggesting it may be a potential strategy to slow the disability progression of the degenerative neurological disorder, according to a report published by JAMA Neurology, a JAMA Network publication. Urate is an end product of human metabolism. Animal experiments suggest that urate may protect against PD, and higher blood urate levels are...

2013-12-18 12:22:56

BURLINGTON, Mass., Dec. 18, 2013 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, will soon publish a comprehensive market analysis and a forecast though 2022 for both the hepatitis C virus (HCV) drug market and the hospital-treated bacterial infections drug market. (Logo: http://photos.prnewswire.com/prnh/20130103/MM36784LOGO ) Key findings from the upcoming Pharmacor advisory service entitled...

2013-12-12 11:06:49

Researchers from Taiwan reveal that antiviral therapy for hepatitis C virus (HCV) improves kidney and cardiovascular outcomes for patients with diabetes. Results of the study published in Hepatology, a journal of the American Association for the Study of Liver Diseases, show that incidences of kidney disease, stroke, and heart attack were lower in patients treated with pegylated interferon and ribavirin compared to HCV patients not treated with antivirals or diabetic patients not infected...

2013-12-10 08:29:59

-Results further confirm phase II studies, with consistent virologic response and tolerability profile- NORTH CHICAGO, Ill., Dec. 10, 2013 /PRNewswire/ -- AbbVie (NYSE: ABBV) released phase III results for the investigational three direct-acting-antiviral (3D) regimen plus ribavirin in patients with chronic, genotype 1 (GT1) hepatitis C virus (HCV) infection. In the 394-patient SAPPHIRE-II study, 96 percent of patients who previously failed pegylated interferon and ribavirin...